Wildeboer Dellelce LLP acted for CTI on the matter. Cytophage Technologies Ltd. (“Cytophage”), formerly Cuspis Capital III Ltd., has completed a reverse take-over (the “RTO”) of…
Cytophage Technologies Ltd.’s Reverse Takeover and TSX Listing


Wildeboer Dellelce LLP acted for CTI on the matter. Cytophage Technologies Ltd. (“Cytophage”), formerly Cuspis Capital III Ltd., has completed a reverse take-over (the “RTO”) of…
…